AFFERENT TECHNOLOGIES SL.

A Healthtech startup included in the Barcelona & Catalonia Startup Hub

AFFERENT TECHNOLOGIES. Barcelona & Catalonia Startup Hub
  1. Startups in Catalonia
  2. Directory
  3. AFFERENT TECHNOLOGIES

AFFERENT TECHNOLOGIES

AFFERENT TECHNOLOGIES SL.
Edifici Eureka · Parc de Recerca UAB (Campus UAB 08193 Cerdanyola del Vallès
http://www.afferent-technologies.com/

Afferent Technologies, innovate in the field of instrumentation for clinical neurophysiology. In particular, it develops a new amplifier and stimulator technology for the central nervous system, peripheral nerves and muscle.

Industries & Technologies

Industries: Healthtech
Technologies: Digital Health
Other fields: Deeptech

Financial data

Funding stage:
Founded: 2016
Employees:

Other information

Business model: Development & Manufacturing
Target: -
Spinoff participants: None / Not a spinoff

Other startups near startup AFFERENT TECHNOLOGIES

similar companies

NEWBORN SOLUTIONS
Newborn solutions is a medical device startup that develops a unique cell counting device that enables screening and monitoring of infections in serous body fluids, with a primary focus on patient...
  • Healthtech
  • Digital Health
  • Industry 4.0
  • Deeptech
DERMAVISION
Creating a novel medical device to enhance melanoma early detection.
  • Healthtech
  • Digital Health
  • Industry 4.0
  • Deeptech
PHARMACELERA
Pharmacelera offers integrated hardware-software solutions, pharmaceutical design based on ligands based on 20 years of research at the University of Barcelona.
  • Healthtech
  • Digital Health
  • Deeptech
  • Scaleup

The Barcelona & Catalonia Startup Hub.

It is a Catalan Government project offering updated information on the Catalan startup ecosystem; gathering and consolidating data from internal databases as well as other local and international sources.

Collaborators of Barcelona & Catalonia Startup Hub.

We teamed up with business associations, universities and startup incubators to create the Barcelona & Catalonia Startup Hub.